FDA Inspection 964410 — DSG Biotec GmbH Institut fur Pharma-Analytik

DSG Biotec GmbH Institut fur Pharma-Analytik — FEI 3005466387

The FDA completed an inspection of DSG Biotec GmbH Institut fur Pharma-Analytik on March 18, 2016 in Aschau. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 18, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Aschau (Germany)